mTOR pathways in cancer and autophagy

Cancers

Volumn 10, Issue 1, 2018, Pages

  Paquette, Mathieu ^a,b   El Houjeiri, Leeanna ^a,b   Pause, Arnim ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Autophagy; Cancer; mTOR; Signaling

Indexed keywords

BECLIN 1; CELL PROTEIN; GLUTAMINE; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA RESPONSE ELEMENT; LEUCINE; LEUCINE TRANSFER RNA LIGASE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; METFORMIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PHOSPHOLIPASE C; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN BCL 2; PROTEIN BNIP3; PROTEIN KINASE B; PROTEIN KINASE D; RAG PROTEIN; RAPAMYCIN; RHEB PROTEIN; SERINE; SERINE THREONINE PROTEIN KINASE ULK1; TARGET OF RAPAMYCIN KINASE; TUBEROUS SCLEROSIS COMPLEX 1; TUBEROUS SCLEROSIS COMPLEX 2; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

AUTOPHAGY; DRUG EFFECT; DRUG RESEARCH; ENERGY; ENERGY METABOLISM; ENZYME ACTIVITY; LYSOSOME; MACROAUTOPHAGY; MALIGNANT NEOPLASM; NUTRIENT AVAILABILITY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 85040817970     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers10010018     Document Type: Review

References (154)

1. Pópulo, H.; Lopes, J.M.; Soares, P. The mTOR signalling pathway in human cancer. Int. J. Mol. Sci. 2012, 13, 1886-1918. [CrossRef] [PubMed]
2. Laplante, M.; Sabatini, D.M. mTOR signaling at a glance. J. Cell Sci. 2009, 122, 3589-3594. [CrossRef] [PubMed]
3. Kohrman, M.H. Emerging treatments in the management of tuberous sclerosis complex. Pediatr. Neurol. 2012, 46, 267-275. [CrossRef] [PubMed]
4. Huang, J.; Manning, B.D. The TSC1-TSC2 complex: A molecular switchboard controlling cell growth. Biochem. J. 2008, 412, 179-190. [CrossRef] [PubMed]
5. Menon, S.; Dibble, C.C.; Talbott, G.; Hoxhaj, G.; Valvezan, A.J.; Takahashi, H.; Cantley, L.C.; Manning, B.D. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 2014, 156, 771-785. [CrossRef] [PubMed]
6. Cai, S.-L.; Tee, A.R.; Short, J.D.; Bergeron, J.M.; Kim, J.; Shen, J.; Guo, R.; Johnson, C.L.; Kiguchi, K.; Walker, C.L. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 2006, 173, 279-289. [CrossRef] [PubMed]
7. Inoki, K.; Li, Y.; Zhu, T.; Wu, J.; Guan, K.-L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 2002, 4, 648-657. [CrossRef] [PubMed]
8. Potter, C.J.; Pedraza, L.G.; Xu, T. Akt regulates growth by directly phosphorylating Tsc2. Nat. Cell Biol. 2002, 4, 658-665. [CrossRef] [PubMed]
9. Gwinn, D.M.; Shackelford, D.B.; Egan, D.F.; Mihaylova, M.M.; Mery, A.; Vasquez, D.S.; Turk, B.E.; Shaw, R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 2008, 30, 214-226. [CrossRef] [PubMed]
10. Inoki, K.; Ouyang, H.; Zhu, T.; Lindvall, C.; Wang, Y.; Zhang, X.; Yang, Q.; Bennett, C.; Harada, Y.; Stankunas, K.; et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006, 126, 955-968. [CrossRef] [PubMed]
11. Smith, E.M.; Finn, S.G.; Tee, A.R.; Browne, G.J.; Proud, C.G. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. J. Biol. Chem. 2005, 280, 18717-18727. [CrossRef] [PubMed]
12. Dibble, C.C.; Elis, W.; Menon, S.; Qin, W.; Klekota, J.; Asara, J.M.; Finan, P.M.; Kwiatkowski, D.J.; Murphy, L.O.; Manning, B.D. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell 2012, 47, 535-546. [CrossRef] [PubMed]
13. Inoki, K.; Li, Y.; Xu, T.; Guan, K.-L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003, 17, 1829-1834. [CrossRef] [PubMed]
14. Zhang, Y.; Gao, X.; Saucedo, L.J.; Ru, B.; Edgar, B.A.; Pan, D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 2003, 5, 578-581. [CrossRef] [PubMed]
15. Tee, A.R.; Manning, B.D.; Roux, P.P.; Cantley, L.C.; Blenis, J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 2003, 13, 1259-1268. [CrossRef]
16. Li, Y.; Inoki, K.; Guan, K.-L. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol. Cell Biol. 2004, 24, 7965-7975. [CrossRef] [PubMed]
17. York, B.; Lou, D.; Noonan, D.J. Tuberin nuclear localization can be regulated by phosphorylation of its carboxyl terminus. Mol. Cancer Res. 2006, 4, 885-897. [CrossRef] [PubMed]
18. Rosner, M.; Freilinger, A.; Hengstschläger, M. Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene 2007, 26, 521-531. [CrossRef] [PubMed]
19. Fawal, M.-A.; Brandt, M.; Djouder, N. MCRS1 binds and couples Rheb to amino acid-dependent mTORC1 activation. Dev. Cell 2015, 33, 67-81. [CrossRef] [PubMed]
20. Sato, T.; Nakashima, A.; Guo, L.; Tamanoi, F. Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J. Biol. Chem. 2009, 284, 12783-12791. [CrossRef] [PubMed]
21. Long, X.; Lin, Y.; Ortiz-Vega, S.; Yonezawa, K.; Avruch, J. Rheb binds and regulates the mTOR kinase. Curr. Biol. 2005, 15, 702-713. [CrossRef] [PubMed]
22. Saucedo, L.J.; Gao, X.; Chiarelli, D.A.; Li, L.; Pan, D.; Edgar, B.A. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat. Cell Biol. 2003, 5, 566-571. [CrossRef] [PubMed]
23. Avruch, J.; Long, X.; Lin, Y.; Ortiz-Vega, S.; Rapley, J.; Papageorgiou, A.; Oshiro, N.; Kikkawa, U. Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor. Biochem. Soc. Trans. 2009, 37, 223-226. [CrossRef] [PubMed]
24. Long, X.; Ortiz-Vega, S.; Lin, Y.; Avruch, J. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J. Biol. Chem. 2005, 280, 23433-23436. [CrossRef] [PubMed]
25. Ghosh, A.P.; Marshall, C.B.; Coric, T.; Shim, E.-H.; Kirkman, R.; Ballestas, M.E.; Ikura, M.; Bjornsti, M.-A.; Sudarshan, S. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma. Oncotarget 2015, 6, 17895-17910. [CrossRef] [PubMed]
26. Kim, D.-H.; Sarbassov, D.D.; Ali, S.M.; King, J.E.; Latek, R.R.; Erdjument-Bromage, H.; Tempst, P.; Sabatini, D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110, 163-175. [CrossRef]
27. Hara, K.; Maruki, Y.; Long, X.; Yoshino, K.; Oshiro, N.; Hidayat, S.; Tokunaga, C.; Avruch, J.; Yonezawa, K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110, 177-189. [CrossRef]
28. Oshiro, N.; Yoshino, K.; Hidayat, S.; Tokunaga, C.; Hara, K.; Eguchi, S.; Avruch, J.; Yonezawa, K. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 2004, 9, 359-366. [CrossRef] [PubMed]
29. Sancak, Y.; Peterson, T.R.; Shaul, Y.D.; Lindquist, R.A.; Thoreen, C.C.; Bar-Peled, L.; Sabatini, D.M. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320, 1496-1501. [CrossRef] [PubMed]
30. Sekiguchi, T.; Hirose, E.; Nakashima, N.; Ii, M.; Nishimoto, T. Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B. J. Biol. Chem. 2001, 276, 7246-7257. [CrossRef] [PubMed]
31. Sancak, Y.; Bar-Peled, L.; Zoncu, R.; Markhard, A.L.; Nada, S.; Sabatini, D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141, 290-303. [CrossRef] [PubMed]
32. Avruch, J.; Long, X.; Ortiz-Vega, S.; Rapley, J.; Papageorgiou, A.; Dai, N. Amino acid regulation of TOR complex 1. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E592-E602. [CrossRef] [PubMed]
33. Kim, E.; Goraksha-Hicks, P.; Li, L.; Neufeld, T.P.; Guan, K.-L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 2008, 10, 935-945. [CrossRef] [PubMed]
34. Bar-Peled, L.; Schweitzer, L.D.; Zoncu, R.; Sabatini, D.M. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012, 150, 1196-1208. [CrossRef] [PubMed]
35. Su, M.-Y.; Morris, K.L.; Kim, D.J.; Fu, Y.; Lawrence, R.; Stjepanovic, G.; Zoncu, R.; Hurley, J.H. Hybrid Structure of the RagA/C-Ragulator mTORC1 Activation Complex. Mol. Cell 2017, 68, 835-846.e3. [CrossRef] [PubMed]
36. Stransky, L.A.; Forgac, M. Amino Acid Availability Modulates Vacuolar H+-ATPase Assembly. J. Biol. Chem. 2015, 290, 27360-27369. [CrossRef] [PubMed]
37. Zoncu, R.; Bar-Peled, L.; Efeyan, A.; Wang, S.; Sancak, Y.; Sabatini, D.M. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 2011, 334, 678-683. [CrossRef] [PubMed]
38. Ögmundsdóttir, M.H.; Heublein, S.; Kazi, S.; Reynolds, B.; Visvalingam, S.M.; Shaw, M.K.; Goberdhan, D.C.I. Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes. PLoS ONE 2012, 7, e36616. [CrossRef] [PubMed]
39. Heublein, S.; Kazi, S.; Ogmundsdóttir, M.H.; Attwood, E.V.; Kala, S.; Boyd, C.A.R.; Wilson, C.; Goberdhan, D.C.I. Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation. Oncogene 2010, 29, 4068-4079. [CrossRef] [PubMed]
40. Zhang, C.-S.; Jiang, B.; Li, M.; Zhu, M.; Peng, Y.; Zhang, Y.-L.; Wu, Y.-Q.; Li, T.Y.; Liang, Y.; Lu, Z.; et al. The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 2014, 20, 526-540. [CrossRef] [PubMed]
41. Zhang, Y.-L.; Guo, H.; Zhang, C.-S.; Lin, S.-Y.; Yin, Z.; Peng, Y.; Luo, H.; Shi, Y.; Lian, G.; Zhang, C.; et al. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab. 2013, 18, 546-555. [CrossRef] [PubMed]
42. Han, J.M.; Jeong, S.J.; Park, M.C.; Kim, G.; Kwon, N.H.; Kim, H.K.; Ha, S.H.; Ryu, S.H.; Kim, S. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012, 149, 410-424. [CrossRef] [PubMed]
43. Bonfils, G.; Jaquenoud, M.; Bontron, S.; Ostrowicz, C.; Ungermann, C.; De Virgilio, C. Leucyl-tRNA synthetase controls TORC1 via the EGO complex. Mol. Cell 2012, 46, 105-110. [CrossRef] [PubMed]
44. Kim, J.H.; Lee, C.; Lee, M.; Wang, H.; Kim, K.; Park, S.J.; Yoon, I.; Jang, J.; Zhao, H.; Kim, H.K.; et al. Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction. Nat. Commun. 2017, 8, 732. [CrossRef] [PubMed]
45. Jewell, J.L.; Kim, Y.C.; Russell, R.C.; Yu, F.-X.; Park, H.W.; Plouffe, S.W.; Tagliabracci, V.S.; Guan, K.-L. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science 2015, 347, 194-198. [CrossRef] [PubMed]
46. Chiu, M.; Tardito, S.; Barilli, A.; Bianchi, M.G.; Dall’Asta, V.; Bussolati, O. Glutamine stimulates mTORC1 independent of the cell content of essential amino acids. Amino Acids 2012, 43, 2561-2567. [CrossRef] [PubMed]
47. Tan, H.W.S.; Sim, A.Y.L.; Long, Y.C. Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation. Nat. Commun. 2017, 8, 338. [CrossRef] [PubMed]
48. Durán, R.V.; Oppliger, W.; Robitaille, A.M.; Heiserich, L.; Skendaj, R.; Gottlieb, E.; Hall, M.N. Glutaminolysis activates Rag-mTORC1 signaling. Mol. Cell 2012, 47, 349-358. [CrossRef] [PubMed]
49. Tsun, Z.-Y.; Bar-Peled, L.; Chantranupong, L.; Zoncu, R.; Wang, T.; Kim, C.; Spooner, E.; Sabatini, D.M. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol. Cell 2013, 52, 495-505. [CrossRef] [PubMed]
50. Péli-Gulli, M.-P.; Sardu, A.; Panchaud, N.; Raucci, S.; De Virgilio, C. Amino Acids Stimulate TORC1 through Lst4-Lst7, a GTPase-Activating Protein Complex for the Rag Family GTPase Gtr2. Cell Rep. 2015, 13, 1-7. [CrossRef] [PubMed]
51. Petit, C.S.; Roczniak-Ferguson, A.; Ferguson, S.M. Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases. J. Cell Biol. 2013, 202, 1107-1122. [CrossRef] [PubMed]
52. Wu, M.; Si, S.; Li, Y.; Schoen, S.; Xiao, G.-Q.; Li, X.; Teh, B.T.; Wu, G.; Chen, J. Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression. Oncotarget 2015, 6, 32761-32773. [CrossRef] [PubMed]
53. Hasumi, Y.; Baba, M.; Hasumi, H.; Huang, Y.; Lang, M.; Reindorf, R.; Oh, H.; Sciarretta, S.; Nagashima, K.; Haines, D.C.; et al. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation. Hum. Mol. Genet. 2014, 23, 5706-5719. [CrossRef] [PubMed]
54. Hudon, V.; Sabourin, S.; Dydensborg, A.B.; Kottis, V.; Ghazi, A.; Paquet, M.; Crosby, K.; Pomerleau, V.; Uetani, N.; Pause, A. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin. J. Med. Genet. 2010, 47, 182-189. [CrossRef] [PubMed]
55. Yan, M.; Audet-Walsh, É.; Manteghi, S.; Rosa Dufour, C.; Walker, B.; Baba, M.; St-Pierre, J.; Giguère, V.; Pause, A. Chronic AMPK activation via loss of FLCN induces functional beige adipose tissue through PGC-1α/ERRα. Genes Dev. 2016, 30, 1034-1046. [CrossRef] [PubMed]
56. Wada, S.; Neinast, M.; Jang, C.; Ibrahim, Y.H.; Lee, G.; Babu, A.; Li, J.; Hoshino, A.; Rowe, G.C.; Rhee, J.; et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes Dev. 2016, 30, 2551-2564. [CrossRef] [PubMed]
57. Possik, E.; Jalali, Z.; Nouët, Y.; Yan, M.; Gingras, M.-C.; Schmeisser, K.; Panaite, L.; Dupuy, F.; Kharitidi, D.; Chotard, L.; et al. Folliculin regulates ampk-dependent autophagy and metabolic stress survival. PLoS Genet. 2014, 10, e1004273. [CrossRef] [PubMed]
58. Yan, M.; Gingras, M.-C.; Dunlop, E.A.; Nouët, Y.; Dupuy, F.; Jalali, Z.; Possik, E.; Coull, B.J.; Kharitidi, D.; Dydensborg, A.B.; et al. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation. J. Clin. Investig. 2014, 124, 2640-2650. [CrossRef] [PubMed]
59. Possik, E.; Ajisebutu, A.; Manteghi, S.; Gingras, M.-C.; Vijayaraghavan, T.; Flamand, M.; Coull, B.; Schmeisser, K.; Duchaine, T.; van Steensel, M.; et al. FLCN and AMPK Confer Resistance to Hyperosmotic Stress via Remodeling of Glycogen Stores. PLoS Genet. 2015, 11, e1005520. [CrossRef] [PubMed]
60. Baba, M.; Hong, S.-B.; Sharma, N.; Warren, M.B.; Nickerson, M.L.; Iwamatsu, A.; Esposito, D.; Gillette, W.K.; Hopkins, R.F.; Hartley, J.L.; et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc. Natl. Acad. Sci. USA 2006, 103, 15552-15557. [CrossRef] [PubMed]
61. Starling, G.P.; Yip, Y.Y.; Sanger, A.; Morton, P.E.; Eden, E.R.; Dodding, M.P. Folliculin directs the formation of a Rab34-RILP complex to control the nutrient-dependent dynamic distribution of lysosomes. EMBO Rep. 2016, 17, 823-841. [CrossRef] [PubMed]
62. Hasumi, H.; Baba, M.; Hasumi, Y.; Furuya, M.; Yao, M. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome. Int. J. Urol. 2016, 23, 204-210. [CrossRef] [PubMed]
63. Dunlop, E.A.; Hunt, D.K.; Acosta-Jaquez, H.A.; Fingar, D.C.; Tee, A.R. ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding. Autophagy 2011, 7, 737-747. [CrossRef] [PubMed]
64. Zhang, C.-S.; Hawley, S.A.; Zong, Y.; Li, M.; Wang, Z.; Gray, A.; Ma, T.; Cui, J.; Feng, J.-W.; Zhu, M.; et al. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature 2017, 548, 112-116. [CrossRef] [PubMed]
65. Ciccia, A.; Elledge, S.J. The DNA damage response: Making it safe to play with knives. Mol. Cell 2010, 40, 179-204. [CrossRef] [PubMed]
66. Cam, H.; Houghton, P.J. Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: Causes and consequences. Target. Oncol. 2011, 6, 95-102. [CrossRef] [PubMed]
67. Semenza, G.L.; Wang, G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 1992, 12, 5447-5454. [CrossRef] [PubMed]
68. Cockman, M.E.; Masson, N.; Mole, D.R.; Jaakkola, P.; Chang, G.W.; Clifford, S.C.; Maher, E.R.; Pugh, C.W.; Ratcliffe, P.J.; Maxwell, P.H. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 2000, 275, 25733-25741. [CrossRef] [PubMed]
69. Bruick, R.K.; McKnight, S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294, 1337-1340. [CrossRef] [PubMed]
70. DeYoung, M.P.; Horak, P.; Sofer, A.; Sgroi, D.; Ellisen, L.W. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 2008, 22, 239-251. [CrossRef] [PubMed]
71. Vega-Rubin-de-Celis, S.; Abdallah, Z.; Kinch, L.; Grishin, N.V.; Brugarolas, J.; Zhang, X. Structural analysis and functional implications of the negative mTORC1 regulator REDD1. Biochemistry 2010, 49, 2491-2501. [CrossRef] [PubMed]
72. Brugarolas, J.; Lei, K.; Hurley, R.L.; Manning, B.D.; Reiling, J.H.; Hafen, E.; Witters, L.A.; Ellisen, L.W.; Kaelin, W.G. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004, 18, 2893-2904. [CrossRef] [PubMed]
73. Li, Y.; Wang, Y.; Kim, E.; Beemiller, P.; Wang, C.-Y.; Swanson, J.; You, M.; Guan, K.-L. Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb. J. Biol. Chem. 2007, 282, 35803-35813. [CrossRef] [PubMed]
74. Klionsky, D.J. The molecular machinery of autophagy: Unanswered questions. J. Cell Sci. 2005, 118, 7-18. [CrossRef] [PubMed]
75. Mizushima, N. Autophagy: Process and function. Genes Dev. 2007, 21, 2861-2873. [CrossRef] [PubMed]
76. Cadwell, K.; Stappenbeck, T.S.; Virgin, H.W. Role of autophagy and autophagy genes in inflammatory bowel disease. Curr. Top MicroBiol. Immunol. 2009, 335, 141-167. [PubMed]
77. Huang, J.; Klionsky, D.J. Autophagy and human disease. Cell Cycle 2007, 6, 1837-1849. [CrossRef] [PubMed]
78. Liang, C.; Jung, J.U. Autophagy genes as tumor suppressors. Curr. Opin. Cell Biol. 2010, 22, 226-233. [CrossRef] [PubMed]
79. Scott, R.C.; Schuldiner, O.; Neufeld, T.P. Role and regulation of starvation-induced autophagy in the Drosophila fat body. Dev. Cell 2004, 7, 167-178. [CrossRef] [PubMed]
80. Morselli, E.; Galluzzi, L.; Kepp, O.; Vicencio, J.-M.; Criollo, A.; Maiuri, M.C.; Kroemer, G. Anti- and pro-tumor functions of autophagy. Biochim. Biophys. Acta 2009, 1793, 1524-1532. [CrossRef] [PubMed]
81. Codogno, P.; Meijer, A.J. Autophagy and signaling: Their role in cell survival and cell death. Cell Death Differ. 2005, 12, 1509-1518. [CrossRef] [PubMed]
82. Oh, W.J.; Wu, C.; Kim, S.J.; Facchinetti, V.; Julien, L.-A.; Finlan, M.; Roux, P.P.; Su, B.; Jacinto, E. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 2010, 29, 3939-3951. [CrossRef] [PubMed]
83. Zinzalla, V.; Stracka, D.; Oppliger, W.; Hall, M.N. Activation of mTORC2 by association with the ribosome. Cell 2011, 144, 757-768. [CrossRef] [PubMed]
84. Ganley, I.G.; Lam, D.H.; Wang, J.; Ding, X.; Chen, S.; Jiang, X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J. Biol. Chem. 2009, 284, 12297-12305. [CrossRef] [PubMed]
85. Hosokawa, N.; Hara, T.; Kaizuka, T.; Kishi, C.; Takamura, A.; Miura, Y.; Iemura, S.; Natsume, T.; Takehana, K.; Yamada, N.; et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 2009, 20, 1981-1991. [CrossRef] [PubMed]
86. Jung, C.H.; Jun, C.B.; Ro, S.-H.; Kim, Y.-M.; Otto, N.M.; Cao, J.; Kundu, M.; Kim, D.-H. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 2009, 20, 1992-2003. [CrossRef] [PubMed]
87. Kim, J.; Kundu, M.; Viollet, B.; Guan, K.-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13, 132-141. [CrossRef] [PubMed]
88. Shang, L.; Chen, S.; Du, F.; Li, S.; Zhao, L.; Wang, X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc. Natl. Acad Sci. USA 2011, 108, 4788-4793. [CrossRef] [PubMed]
89. Nazio, F.; Strappazzon, F.; Antonioli, M.; Bielli, P.; Cianfanelli, V.; Bordi, M.; Gretzmeier, C.; Dengjel, J.; Piacentini, M.; Fimia, G.M.; et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat. Cell Biol. 2013, 15, 406-416. [CrossRef] [PubMed]
90. Bach, M.; Larance, M.; James, D.E.; Ramm, G. The serine/threonine kinase ULK1 is a target of multiple phosphorylation events. Biochem. J. 2011, 440, 283-291. [CrossRef] [PubMed]
91. Egan, D.F.; Shackelford, D.B.; Mihaylova, M.M.; Gelino, S.; Kohnz, R.A.; Mair, W.; Vasquez, D.S.; Joshi, A.; Gwinn, D.M.; Taylor, R.; et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331, 456-461. [CrossRef] [PubMed]
92. Lee, J.W.; Park, S.; Takahashi, Y.; Wang, H.-G. The association of AMPK with ULK1 regulates autophagy. PLoS ONE 2010, 5, e15394. [CrossRef] [PubMed]
93. Jung, C.H.; Seo, M.; Otto, N.M.; Kim, D.-H. ULK1 inhibits the kinase activity of mTORC1 and cell proliferation. Autophagy 2011, 7, 1212-1221. [CrossRef] [PubMed]
94. Di Bartolomeo, S.; Corazzari, M.; Nazio, F.; Oliverio, S.; Lisi, G.; Antonioli, M.; Pagliarini, V.; Matteoni, S.; Fuoco, C.; Giunta, L.; et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J. Cell Biol. 2010, 191, 155-168. [CrossRef] [PubMed]
95. Russell, R.C.; Tian, Y.; Yuan, H.; Park, H.W.; Chang, Y.-Y.; Kim, J.; Kim, H.; Neufeld, T.P.; Dillin, A.; Guan, K.-L. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 2013, 15, 741-750. [CrossRef] [PubMed]
96. Matsunaga, K.; Morita, E.; Saitoh, T.; Akira, S.; Ktistakis, N.T.; Izumi, T.; Noda, T.; Yoshimori, T. Autophagy requires endoplasmic reticulum targeting of the PI3-kinase complex via Atg14L. J. Cell Biol. 2010, 190, 511-521. [CrossRef] [PubMed]
97. Wold, M.S.; Lim, J.; Lachance, V.; Deng, Z.; Yue, Z. ULK1-mediated phosphorylation of ATG14 promotes autophagy and is impaired in Huntington’s disease models. Mol. Neurodegener. 2016, 11, 76. [CrossRef] [PubMed]
98. Yuan, H.-X.; Russell, R.C.; Guan, K.-L. Regulation of PIK3C3/VPS34 complexes by mTOR in nutrient stress-induced autophagy. Autophagy 2013, 9, 1983-1995. [CrossRef] [PubMed]
99. Löffler, A.S.; Alers, S.; Dieterle, A.M.; Keppeler, H.; Franz-Wachtel, M.; Kundu, M.; Campbell, D.G.; Wesselborg, S.; Alessi, D.R.; Stork, B. Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. Autophagy 2011, 7, 696-706. [CrossRef] [PubMed]
100. Koren, I.; Reem, E.; Kimchi, A. DAP1, a novel substrate of mTOR, negatively regulates autophagy. Curr. Biol. 2010, 20, 1093-1098. [CrossRef] [PubMed]
101. Hsu, P.P.; Kang, S.A.; Rameseder, J.; Zhang, Y.; Ottina, K.A.; Lim, D.; Peterson, T.R.; Choi, Y.; Gray, N.S.; Yaffe, M.B.; et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011, 332, 1317-1322. [CrossRef] [PubMed]
102. Lim, J.; Lachenmayer, M.L.; Wu, S.; Liu, W.; Kundu, M.; Wang, R.; Komatsu, M.; Oh, Y.J.; Zhao, Y.; Yue, Z. Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates. PLoS Genet. 2015, 11, e1004987. [CrossRef] [PubMed]
103. Martina, J.A.; Chen, Y.; Gucek, M.; Puertollano, R. mTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 2012, 8, 903-914. [CrossRef] [PubMed]
104. Roczniak-Ferguson, A.; Petit, C.S.; Froehlich, F.; Qian, S.; Ky, J.; Angarola, B.; Walther, T.C.; Ferguson, S.M. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 2012, 5, ra42. [CrossRef] [PubMed]
105. Settembre, C.; Zoncu, R.; Medina, D.L.; Vetrini, F.; Erdin, S.; Erdin, S.; Huynh, T.; Ferron, M.; Karsenty, G.; Vellard, M.C.; et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012, 31, 1095-1108. [CrossRef] [PubMed]
106. Vega-Rubin-de-Celis, S.; Peña-Llopis, S.; Konda, M.; Brugarolas, J. Multistep regulation of TFEB by mTORC1. Autophagy 2017, 13, 464-472. [CrossRef] [PubMed]
107. Settembre, C.; Di Malta, C.; Polito, V.A.; Garcia Arencibia, M.; Vetrini, F.; Erdin, S.; Erdin, S.U.; Huynh, T.; Medina, D.; Colella, P.; et al. TFEB links autophagy to lysosomal biogenesis. Science 2011, 332, 1429-1433. [CrossRef] [PubMed]
108. Martina, J.A.; Diab, H.I.; Lishu, L.; Jeong A L.; Patange, S.; Raben, N.; Puertollano, R. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci. Signal. 2014, 7, ra9. [CrossRef] [PubMed]
109. Martina, J.A.; Puertollano, R. Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes. J. Cell Biol. 2013, 200, 475-491. [CrossRef] [PubMed]
110. Young, N.P.; Kamireddy, A.; Van Nostrand, J.L.; Eichner, L.J.; Shokhirev, M.N.; Dayn, Y.; Shaw, R.J. AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes. Genes Dev. 2016, 30, 535-552. [CrossRef] [PubMed]
111. Shin, H.-J.R.; Kim, H.; Oh, S.; Lee, J.-G.; Kee, M.; Ko, H.-J.; Kweon, M.-N.; Won, K.-J.; Baek, S.H. AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature 2016, 534, 553-557. [CrossRef] [PubMed]
112. Kim, Y.C.; Park, H.W.; Sciarretta, S.; Mo, J.-S.; Jewell, J.L.; Russell, R.C.; Wu, X.; Sadoshima, J.; Guan, K.-L. Rag GTPases are cardioprotective by regulating lysosomal function. Nat. Commun. 2014, 5, 4241. [CrossRef] [PubMed]
113. Najibi, M.; Labed, S.A.; Visvikis, O.; Irazoqui, J.E. An Evolutionarily Conserved PLC-PKD-TFEB Pathway for Host Defense. Cell Rep. 2016, 15, 1728-1742. [CrossRef] [PubMed]
114. Pastore, N.; Brady, O.A.; Diab, H.I.; Martina, J.A.; Sun, L.; Huynh, T.; Lim, J.-A.; Zare, H.; Raben, N.; Ballabio, A.; et al. TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages. Autophagy 2016, 12, 1240-1258. [CrossRef] [PubMed]
115. Visvikis, O.; Ihuegbu, N.; Labed, S.A.; Luhachack, L.G.; Alves, A.-M.F.; Wollenberg, A.C.; Stuart, L.M.; Stormo, G.D.; Irazoqui, J.E. Innate host defense requires TFEB-mediated transcription of cytoprotective and antimicrobial genes. Immunity 2014, 40, 896-909. [CrossRef] [PubMed]
116. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867. [CrossRef] [PubMed]
117. White, E.; DiPaola, R.S. The double-edged sword of autophagy modulation in cancer. Clin. Cancer Res. 2009, 15, 5308-5316. [CrossRef] [PubMed]
118. Galluzzi, L.; Pietrocola, F.; Bravo-San Pedro, J.M.; Amaravadi, R.K.; Baehrecke, E.H.; Cecconi, F.; Codogno, P.; Debnath, J.; Gewirtz, D.A.; Karantza, V.; et al. Autophagy in malignant transformation and cancer progression. EMBO J. 2015, 34, 856-880. [CrossRef] [PubMed]
119. Amaravadi, R.; Kimmelman, A.C.; White, E. Recent insights into the function of autophagy in cancer. Genes Dev. 2016, 30, 1913-1930. [CrossRef] [PubMed]
120. Levy, J.M.M.; Thorburn, A. Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol. Ther. 2011, 131, 130-141. [CrossRef] [PubMed]
121. Towers, C.G.; Thorburn, A. Therapeutic targeting of autophagy. EBioMedicine 2016, 14, 15-23. [CrossRef] [PubMed]
122. Meijer, A.J.; Codogno, P. Regulation and role of autophagy in mammalian cells. Int. J. Biochem. Cell Biol. 2004, 36, 2445-2462. [CrossRef] [PubMed]
123. Ogier-Denis, E.; Codogno, P. Autophagy: A barrier or an adaptive response to cancer. Biochim. Biophys. Acta 2003, 1603, 113-128. [CrossRef]
124. Degenhardt, K.; Mathew, R.; Beaudoin, B.; Bray, K.; Anderson, D.; Chen, G.; Mukherjee, C.; Shi, Y.; Gélinas, C.; Fan, Y.; et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10, 51-64. [CrossRef] [PubMed]
125. Mazure, N.M.; Pouysségur, J. Hypoxia-induced autophagy: Cell death or cell survival? Curr. Opin. Cell Biol. 2010, 22, 177-180. [CrossRef] [PubMed]
126. Chen, N.; Karantza, V. Autophagy as a therapeutic target in cancer. Cancer Biol. Ther. 2011, 11, 157-168. [CrossRef] [PubMed]
127. Levine, B.; Klionsky, D.J. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6, 463-477. [CrossRef]
128. Lu, Z.; Luo, R.Z.; Lu, Y.; Zhang, X.; Yu, Q.; Khare, S.; Kondo, S.; Kondo, Y.; Yu, Y.; Mills, G.B.; et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J. Clin. Investig. 2008, 118, 3917-3929. [CrossRef] [PubMed]
129. Apel, A.; Zentgraf, H.; Büchler, M.W.; Herr, I. Autophagy-A double-edged sword in oncology. Int. J. Cancer 2009, 125, 991-995. [CrossRef] [PubMed]
130. Brech, A.; Ahlquist, T.; Lothe, R.A.; Stenmark, H. Autophagy in tumour suppression and promotion. Mol. Oncol. 2009, 3, 366-375. [CrossRef] [PubMed]
131. Dalby, K.N.; Tekedereli, I.; Lopez-Berestein, G.; Ozpolat, B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010, 6, 322-329. [CrossRef] [PubMed]
132. Levine, B. Cell biology: Autophagy and cancer. Nature 2007, 446, 745-747. [CrossRef] [PubMed]
133. Mathew, R.; Karantza-Wadsworth, V.; White, E. Role of autophagy in cancer. Nat. Rev. Cancer 2007, 7, 961-967. [CrossRef] [PubMed]
134. Shen, S.; Kepp, O.; Michaud, M.; Martins, I.; Minoux, H.; Métivier, D.; Maiuri, M.C.; Kroemer, R.T.; Kroemer, G. Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 2011, 30, 4544-4556. [CrossRef] [PubMed]
135. Amaravadi, R.K.; Lippincott-Schwartz, J.; Yin, X.-M.; Weiss, W.A.; Takebe, N.; Timmer, W.; DiPaola, R.S.; Lotze, M.T.; White, E. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17, 654-666. [CrossRef] [PubMed]
136. Choi, A.M.K.; Ryter, S.W.; Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 2013, 368, 651-662. [CrossRef] [PubMed]
137. Evans, J.M.M.; Donnelly, L.A.; Emslie-Smith, A.M.; Alessi, D.R.; Morris, A.D. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005, 330, 1304-1305. [CrossRef] [PubMed]
138. Harrison, D.E.; Strong, R.; Sharp, Z.D.; Nelson, J.F.; Astle, C.M.; Flurkey, K.; Nadon, N.L.; Wilkinson, J.E.; Frenkel, K.; Carter, C.S.; et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460, 392-395. [CrossRef] [PubMed]
139. Kim, Y.C.; Guan, K.-L. mTOR: A pharmacologic target for autophagy regulation. J. Clin. Investig. 2015, 125, 25-32. [CrossRef] [PubMed]
140. Shimobayashi, M.; Hall, M.N. Making new contacts: The mTOR network in metabolism and signalling crosstalk. Nat. Rev. Mol. Cell Biol. 2014, 15, 155-162. [CrossRef] [PubMed]
141. Aylett, C.H.S.; Sauer, E.; Imseng, S.; Boehringer, D.; Hall, M.N.; Ban, N.; Maier, T. Architecture of human mTOR complex 1. Science 2016, 351, 48-52. [CrossRef] [PubMed]
142. Chagin, A.S. Effectors of mTOR-autophagy pathway: Targeting cancer, affecting the skeleton. Curr. Opin. Pharmacol. 2016, 28, 1-7. [CrossRef] [PubMed]
143. Brachmann, S.; Fritsch, C.; Maira, S.-M.; García-Echeverría, C. PI3K and mTOR inhibitors: A new generation of targeted anticancer agents. Curr. Opin. Cell Biol. 2009, 21, 194-198. [CrossRef] [PubMed]
144. Takeuchi, H.; Kondo, Y.; Fujiwara, K.; Kanzawa, T.; Aoki, H.; Mills, G.B.; Kondo, S. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 2005, 65, 3336-3346. [CrossRef] [PubMed]
145. Ravikumar, B.; Duden, R.; Rubinsztein, D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 2002, 11, 1107-1117. [CrossRef] [PubMed]
146. Nam, H.Y.; Han, M.W.; Chang, H.W.; Kim, S.Y.; Kim, S.W. Prolonged autophagy by mTOR inhibitor leads radioresistant cancer cells into senescence. Autophagy 2013, 9, 1631-1632. [CrossRef] [PubMed]
147. Parkhitko, A.A.; Priolo, C.; Coloff, J.L.; Yun, J.; Wu, J.J.; Mizumura, K.; Xu, W.; Malinowska, I.A.; Yu, J.; Kwiatkowski, D.J.; et al. Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide. Mol. Cancer Res. 2014, 12, 48-57. [CrossRef] [PubMed]
148. Thoreen, C.C.; Kang, S.A.; Chang, J.W.; Liu, Q.; Zhang, J.; Gao, Y.; Reichling, L.J.; Sim, T.; Sabatini, D.M.; Gray, N.S. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 2009, 284, 8023-8032. [CrossRef] [PubMed]
149. Rodrik-Outmezguine, V.S.; Okaniwa, M.; Yao, Z.; Novotny, C.J.; McWhirter, C.; Banaji, A.; Won, H.; Wong, W.; Berger, M.; de Stanchina, E.; et al. Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature 2016, 534, 272-276. [CrossRef] [PubMed]
150. Hardie, D.G. Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett. 2008, 582, 81-89. [CrossRef] [PubMed]
151. Tomic, T.; Botton, T.; Cerezo, M.; Robert, G.; Luciano, F.; Puissant, A.; Gounon, P.; Allegra, M.; Bertolotto, C.; Bereder, J.-M.; et al. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis. 2011, 2, e199. [CrossRef] [PubMed]
152. Shi, W.-Y.; Xiao, D.; Wang, L.; Dong, L.-H.; Yan, Z.-X.; Shen, Z.-X.; Chen, S.-J.; Chen, Y.; Zhao, W.-L. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis. 2012, 3, e275. [CrossRef] [PubMed]
153. Feng, Y.; Ke, C.; Tang, Q.; Dong, H.; Zheng, X.; Lin, W.; Ke, J.; Huang, J.; Yeung, S.-C.J.; Zhang, H. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Cell Death Dis. 2014, 5, e1088. [CrossRef] [PubMed]
154. Nazim, U.M.; Moon, J.-H.; Lee, J.-H.; Lee, Y.-J.; Seol, J.-W.; Eo, S.-K.; Lee, J.-H.; Park, S.-Y. Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL-induced apoptosis. Oncotarget 2016, 7, 23468-23481. [CrossRef] [PubMed]